期刊文献+

乳腺癌c—erbB—2、nm23基因表达的临床意义研究 被引量:3

下载PDF
导出
摘要 目的 讨论c—erbB—2、nm23基因表达对乳腺癌淋巴结转移的影响。方法 选择淋巴结转移和无淋巴结转移的乳腺癌术后石蜡包埋标本各43例行免疫组化染色(SP法)。结果 ①c—erbB—2在淋巴结转移组表达阳性率65%,非淋巴结转移组阳性率58%,两组表达差别无显著意义;nm23淋巴结转移组阳性率60%,淋巴结转移阴性组阳性率58%,两组未见显著差别。②基因超表达分析:c—erbB—2在淋巴结转移组中强阳性率39%,在非淋巴结转移组中强阳性率19%,差别有显著意义(P<0.05);nm23在两组中强阳性率分别为23%及43%。差别有显著意义(p<0.05)。结论 c—erbB—2超表达对淋巴结转移表现促进作用,nm23对淋巴结转移表现抑制作用。
出处 《实用肿瘤学杂志》 CAS 1999年第3期223-224,共2页 Practical Oncology Journal
  • 相关文献

同被引文献24

  • 1刘彦仿.免疫组织化学[M].北京:人民教育出版社,1994.51.
  • 2Chaudary MA,Millis RR,Hoskims EOL,et al.Bilateral primary breast cancer:a prospective study of disease incidence[J].Br J Surg,1984,71(9):711.
  • 3Safal M,Lower EE,Hasselgren PO,et al.Bilateral synchronous breast cancer and Her-2/neu overexpression[J].Breast Cancer Research and Treatment,2002,72(3):195.
  • 4Kinoshita T,Ueda M,Enomoto K,et al.Comparison of p53 gene abnormalities in bilateral and unilateral breast cancer[J].Cancer,1995,76(12):2504.
  • 5Heron DE,Komarnicky LT,Hyslop T,et al.Bilateral breast carcinoma:risk factors and outcomes for patients with synchronous and metachronous disease[J].Cancer,2000,88(12):2739.
  • 6左文述.双侧原发性乳腺癌18例报告[J].实用癌症杂志,1988,3(3):146-146.
  • 7Urban JA,Papachristou D,Taylor J.Bilateral breast cancer-biopsy of the opposite breast[J].Cancer,1977,40(4):1968.
  • 8Kollias J,Ellis IO,Elston CW,et al.Prognostic significance of synchronous and metachronous bilateral breast cancer[J].World J Surg,2001,25(9):1117.
  • 9Janschek E,Kandioler-Eckersberger D,Ludwig C,et al.Contralateral breast cancer:molecular differentiation between metastasis and second primary cancer[J].Breast Cancer Research and Treatment,2001,67(1):1.
  • 10Chang F,Syrjanen S,Tervahauta A,et al.Tumourigenesis associated with the p53 tumor suppressor gene[J].Br J Cancer,1993,68(4):653.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部